Most Recent Articles by Laura Entis
Five things for pharma marketers to know: Tuesday, August 28, 2018
Aug 28, 2018Gilead's CAR-T cell therapy ruled too expensive in the U.K.; Experts mixed on impact of drug price hike freezes; Women turn to wearables for fertility tracking
Five things for pharma marketers to know: Monday, August 27, 2018
Aug 27, 2018Pfizer's drug tafamidis reduces risk of death; Lilly Diabetes pulls its sponsorship of Daly's car; FDA investigates electronic cigarette maker Juul.
Got name? A peek into the sometimes bizarre land of pharma brand-naming
Aug 27, 2018As more medications are approved, pharma companies are being pushed farther afield into a land of bizarre — but hopefully still memorable and vaguely meaningful — drug names.
Novo Nordisk's Ozempic takes on Lilly's Trulicity in DTC showdown
Aug 20, 2018The two diabetes rivals air competing TV spots as they compete for GLP-1 supremacy.
Five things for pharma marketers to know: Monday, August 20, 2018
Aug 20, 2018Azar says HHS can eliminate rebates; States pass measures to stop drug price increases; 'Poor oversight' blamed for California sitting on cash to treat mentally ill.
